切换至 "中华医学电子期刊资源库"

中华眼科医学杂志(电子版) ›› 2019, Vol. 09 ›› Issue (06) : 354 -359. doi: 10.3877/cma.j.issn.2095-2007.2019.06.006

论著

联合激光与传统药物治疗原发性闭角型青光眼急性发作期的临床研究
张新1, 郭黎霞1, 吕爱国1, 张志宏1, 崔宏宇1, 杨艳萍1, 邵培刚1, 范肃洁1,()   
  1. 1. 056001 邯郸市眼科医院(邯郸市第三医院)眼科
  • 收稿日期:2019-08-22 出版日期:2019-12-28
  • 通信作者: 范肃洁
  • 基金资助:
    河北省医学适用技术跟踪项目(GL2012088)

An observation on the treatment of primary acute angle-closure glaucoma with combined laser surgery and traditional medicine

Xin Zhang1, Lixia Guo1, Aiguo Lyn1, Zhihong Zhang1, Hongyu Cui1, Yanping Yang1, Peigang Shao1, Sujie Fan1,()   

  1. 1. Department of Ophthalmology, Handan City Eye Hospital(The Third Hospital of Handan), Handan 056001, China
  • Received:2019-08-22 Published:2019-12-28
  • Corresponding author: Sujie Fan
引用本文:

张新, 郭黎霞, 吕爱国, 张志宏, 崔宏宇, 杨艳萍, 邵培刚, 范肃洁. 联合激光与传统药物治疗原发性闭角型青光眼急性发作期的临床研究[J]. 中华眼科医学杂志(电子版), 2019, 09(06): 354-359.

Xin Zhang, Lixia Guo, Aiguo Lyn, Zhihong Zhang, Hongyu Cui, Yanping Yang, Peigang Shao, Sujie Fan. An observation on the treatment of primary acute angle-closure glaucoma with combined laser surgery and traditional medicine[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2019, 09(06): 354-359.

目的

评价激光周边虹膜成形术联合激光瞳孔成形术与传统降眼压药物治疗原发性闭角型青光眼急性发作的有效性和安全性。

方法

收集2014年1月至2015年7月于邯郸市眼科医院(邯郸市第三医院)就诊的62例(68只眼)确诊为原发性闭角型青光眼首次急性发作并未做降眼压治疗患者的病例资料。其中,男性15例(17只眼),女性47例(51只眼),平均年龄(67.5±8.5)岁,所有患者眼压升高≥40 mmHg(1 mmHg=0.133 kPa)。将入选患者采用数字表法随机分为激光组和药物组。激光组给予激光周边虹膜成形术联合激光瞳孔成形术治疗,药物组给予传统降眼压药物治疗。采用TA03型Icare眼压计测量治疗前、治疗后1 h和2 h的眼压,记录两组角膜及前房情况。以治疗后2 h眼压降至30 mmHg及以下为抢救成功,反之则为治疗失败。激光组和药物组年龄、就诊时眼压和发作时间等资料的描述采用均数±标准差表示,组间比较使用独立样本t检验;两组治疗成功率的描述采用眼数和百分比,比较采用χ2检验;两组治疗前、治疗后1 h和2 h眼压的比较采用两因素重复测量方差分析。

结果

治疗后1 h激光组14只眼抢救成功,成功率为41.2%;药物组15只眼抢救成功,成功率为44.2%。治疗后2 h激光组18只眼抢救成功,成功率为52.9%;药物组20只眼抢救成功,成功率为58.2%。治疗后1 h与2 h两组间成功率无统计学意义( χ2=0.06,0.24;P>0.05)。激光组治疗前视力为光感至0.4,治疗后1 h视力为眼前手动至0.6,治疗后2 h视力为眼前手动至0.6。药物组治疗前视力为光感至0.4,治疗后1 h视力为光感至0.8,治疗后2 h视力为光感至0.8。两组主要并发症为前房内炎症反应和角膜内皮皱褶,无眼内感染和脉络膜下暴发性出血等严重并发症。激光组治疗前、治疗后1 h和2 h平均眼压分别为(56.9±8.7)mmHg、(37.9±16.2)mmHg和(32.9±16.4)mmHg,治疗后眼压下降,与治疗前的比较差异有统计学意义(t=6.02,7.76;P<0.05)。药物组治疗前、治疗后1 h和2 h平均眼压分别为(55.8±9.5)mmHg、(37.6±17.7)mmHg和(30.6±18.2)mmHg,治疗后眼压下降,与治疗前的比较差异有统计学意义(t=5.28,7.16;P<0.05)。但两组各时间点的眼压比较均无统计学意义(t=0.89,0.58,0.85;P>0.05)。

结论

激光周边虹膜成形术联合激光瞳孔成形术和传统的降眼压药物治疗均能快速降低原发性闭角型青光眼急性发作期的眼压,但激光治疗安全、有效,可避免药物治疗给机体带来的副作用,是治疗原发性闭角型青光眼急性发作期的重要辅助措施。

Objective

The aim of this study was to evaluate the efficacy and safety of laser peripheral iridoplasty combined with laser pupil plasty in the treatment of acute primary angle-closure glaucoma.

Methods

From January 2014 to July 2015, sixty-two patients in Handan Eye Hospital (the Third Hospital of Handan) with acute primary angle-closure glaucoma (68 eyes) who were not treated with intraocular pressure reduction for the first acute attack were collected. Among them, 15 cases (17 eyes) were male and 47 cases (51 eyes) were female with an average age of 67.5±8.5 years. All patients had intraocular pressure≥40 mmHg (1 mmHg=0.133 kPa). The enrolled patients were randomly divided into two groups: laser treatment group and drug group. The laser treatment group was treated with combined laser (laser peripheral iridoplasty combined with laser pupil plasty), and drug group was treated with traditional medication. Intraocular pressure was measured by TA03 Icare tonometer before treatment, 1 h and 2 h after treatment, respectively. Changes of cornea and anterior chamber were recorded between groups. Rescue was successful when intraocular pressure dropped to 30 mmHg or below after 2 h of treatment, and failure to control intraocular pressure below 30 mmHg after 2 h of treatment was failed treatment. Age, intraocular pressure and onset time in the laser and drug groups were described by mean ± standard deviation. Independent sample t-test was used for inter-group comparison. The number of eyes and percentage were used to describe the power of two components, and chi-square test was used to compare. The comparison of intraocular pressure between two groups before treatment, 1 h and 2 h after treatment was performed by two-factor repeated measurement analysis of variance.

Results

After 1 h after treatment, 14 eyes in the laser group were successfully rescued, with a success rate of 41.2%; 15 eyes in the drug group were successfully rescued, with a success rate of 44.2%; 18 eyes in the 2 h after treatment, laser group were successfully rescued, with a success rate of 52.9%; 20 eyes in the drug group were successfully rescued, with a success rate of 58.2%. There was no statistical difference in success rate between two groups after 1 h and 2 h after treatment (χ2=0.06, 0.24; P>0.05). The visual acuity of the laser group was light perception to 0.4 before treatment, hand moving to 0.6 after 1 h after treatment, and hand moving to 0.6 after 2 h after treatment. The visual acuity of the drug group was light perception 0.4 before treatment, light perception to 0.8 after 1 h after treatment, and light perception to 0.8 after 2 h after treatment. The main complications in two groups were inflammation in the anterior chamber and corneal endothelium fold, but there were no serious complications such as intraocular infection and subchoroidal hemorrhage. The mean intraocular pressure in the laser group was (56.9±8.7) mmHg, (37.9±16.2) mmHg and (32.9±16.4) mmHg before treatment, 1 h and 2 h after treatment, respectively. Intraocular pressure decreased after treatment, and the difference was statistically significant (t=6.02, 7.76; P<0.05). The mean intraocular pressure in the drug group was (55.8±9.5) mmHg, (37.6±17.7) mmHg and (30.6±18.2) mmHg before and after treatment for 1 h and 2 h, respectively. Intraocular pressure decreased after treatment, and the difference was statistically significant (t=5.28, 7.16; P<0.05). However, there was no statistical difference in intraocular pressure between two groups at each time point (t=0.89, 0.58, 0.85; P>0.05).

Conclusions

Both combined laser therapy and traditional therapy can rapidly reduce intraocular pressure during acute attack of primary angle-closure glaucoma. Laser therapy is safe and effective, it can avoid the side effects of drug therapy to the body, and it is an important adjuvant therapy in the treatment of acute attack of acute primary angle-closure glaucoma.

表1 激光组与药物组患者一般资料的比较
表2 激光组与药物组患者抢救成功率的比较[%(眼数/总眼数)]
表3 激光组与药物组患者眼压下降率的比较
[1]
Sng CCA, Aquino MCD, Liao J, et al. Pretreatment anterior segment imaging during acute primary angle closure: Insights into angle closure mechanisms in the acute phase[J]. Ophthalmology, 2014, 1(1): 119-125.
[2]
Yong KL, Gong, T, Nongpiur, ME, et al. Myopia in Asian subjects with primary angle closure: Implications for glaucoma trends in East Asia[J]. Ophthalmology, 2014, 8(8): 1566-1571.
[3]
Liang Y, Friedman DS, Zhou Q, el al. Prevalence and characteristics of primary angle-closure diseases in a rural adult Chinese population: the Handan Eye Study[J]. Invest Ophthalmol Vis Sci, 2011, 52(12): 8672-8679.
[4]
Hill K, Whitney J, Trotter R, et al. Intravenous hypertonic urea in the management of angle closure glaucoma[J]. Arch Ophthalmol, 1961, 65(4): 497-503.
[5]
赵博,王永毅,柴珺,等.青光眼高眼压状态下复合式小梁切除术的效果[J].中华眼外伤职业眼病杂志2013, 35(7): 529-532.
[6]
范肃洁,孙兰萍,段志娟,等. 激光虹膜成形术治疗急性闭角型青光眼[J]. 眼外伤职业眼病杂志2005, 27(3): 191-192.
[7]
Baudouin C, Denoyer A, Rostène W.Glaucoma today: detection and therapeutic progress[J]. Biol Aujourdhui, 2013, 207(2): 87-95.
[8]
Quigley HA, Congdon NG, Friedman DS. Glaucoma in China (and worldwide): changes inestablished thinking will decrease preventable blindness[J]. Br J Ophthalmol, 2001, 85(11): 1271-1272.
[9]
He M, Foster PJ, Ge J, et al. Prevalence and clinical characteristics of glaucoma in adult Chinese: apopulation-based study in Liwan District, Guangzhou[J]. Invest Ophthalmol Vis Sci, 2006, 47(7): 2782-2788.
[10]
Xu L, Zhang L, Xia CR, et al. [The prevalence and its effective factors of primary angle-closure glaucoma in defined populations of rural and urban in Beijing[J]. Zhonghua Yan Ke Za Zhi, 2005, 41(1): 8-14.
[11]
Jonas JB, George R, Asokan R,et al.Prevalence and causes of vision loss in Central and South Asia: 1990 to 2010[J].Br J Ophthalmol, 2014, 98(5): 592-598.
[12]
Liang YB, Friedman DS, Wong TY,et al.Prevalence and causes of low vision and blindness in a rural chinese adult population: the Handan Eye Study[J]. Ophthalmology, 2008, 115(11): 1965-1972.
[13]
Ge J, He M, Zhao J,et al.Prevalence of blindness and moderate and severe visual impairment among adults aged 50 years or above in Yangxi County of Guangdong Province: the China Nine-Province Survey[J]. Zhonghua Yan Ke Za Zhi, 2014, 50(3): 167-172.
[14]
Teikari J, Raivio I, Nurminen M.Incidence of acute glaucoma inFinland from 1973 to 1982[J].Graefes Arch Clin Exp Ophthalmol, 1987, 225 (5): 357-360.
[15]
Ramesh S, Maw C, Sutton CJ,et a1.Ethnic aspects of acute primary angle closure in a UK mulicultural conurbation[J].Eye (Lond), 2005, 19 (12): 1271-1275.
[16]
Erie JC, Hodge DO, Gray DT. The incidence of primary angle closure glaucoma in Olmsted County, Minnesota[J]. Arch Ophthamol, 1997, 115(2): 177-181.
[17]
Ivaniseviĉ M, Erceg M, Smoljanoviĉ A, et a1. The Incidence andseasonal variations of acute primary angle-closure glaucoma[J]. Coll Antropol, 2002, 26(1): 41-45.
[18]
Bojiĉ L, Mandiĉ Z, Ivaniseviĉ M, et a1. Incidence of acute angle closure glaucoma in dalmatia,southern Croatia[J]. Croat Med J, 2004, 45(3): 279-282.
[19]
Bojiĉ L, Rogosiĉ V, Kovaciĉ Z,et a1. Incidence of acute angle closure attacksin Split-Dalmatia County,Croatia[J]. Acta Clin Croat, 2012, 51(3): 397-401.
[20]
Seah SK, Foster PJ, Chew PT, et a1.Incidence of acute primaryangle closure glaucoma in Singapore: An islandwide survey[J].Arch Ophthalmol, 1997, 115(11): 1436-1440.
[21]
David R, Tessler Z, Yassur Y. Epidemiology of acute angle-closure glaucoma: incidence and seasonal variations[J]. Ophthalmologica, 1985, 191(1): 4-7.
[22]
Lai JS, Liu DT, Tham CC, et a1. Epidemiology of acute primaryangle-closure glaucoma in the Hong Kong Chinese population:prospective study[J]. Hong Kong Med J, 2001, 7(2): 118-123.
[23]
李思珍,梁远波,王宁利,等. 周边虹膜前粘连范围对激光周边虹膜成形术治疗原发性闭角型青光眼急性发作期效果的影响[J]. 眼科2019, 28(1): 23-28.
[24]
王宁利,牟大鹏,王怀洲,等. 急性闭角型青光眼治疗规范探讨[J]. 眼科2015, 24(1): 7.
[25]
Lam DS, Chua JK, Tham CC, et al.Efficacy and safety of immediate anterior chamber paracentesis in the treatment of acute primary angle-closure glaucoma: a pilot study[J].Ophthalmology, 2002, 109(1): 64-70.
[26]
York K, Ritch R, Szmyd LJ. Argon laser peripheral iridoplasty: indications, techniques and results[J]. Invest Ophthalmol Vis Sci, 1984, 25: 94.
[27]
Ritch R, Liebmann JM.Argon laser peripheral iridoplasty[J].Ophthalmic Surg Lasers, 1996, 27(4): 289-300.
[28]
Ritch R. Techniques of Argon laser iridectomy and iridoplasty[M]. Palo Alto, CA: Coherent Medical Press, 1983.
[29]
Ritch R. Argon laser treatment for medically unresponsive attacks of angle closure glaucoma[J]. Am J Ophthalmol, 1982, 94(2): 197-204.
[30]
Ritch R. Argon laser peripheral iridoplasty: an overview[J]. Sur Ophthalmol, 1992, 52(3): 279-288.
[31]
Shin DH. Argon laser treatment for relief of medically unresponsive angle-closure glaucoma attacks[J]. Am J Ophthalmol, 1982, 94(6): 821-822.
[32]
Sassani JW, Ritch R, McCormick S, el al. Histopathology of argon laserperipheral iridoplasty[J].Ophthalmic Surg, 1993, 24(11): 740-745.
[33]
谢成益,周波,王道升,等. 激光周边虹膜成形术在眼科的应用[J]. 眼外伤职业眼病杂志2009, 31(1): 78-80.
[34]
Mahar PS, Laghari D, Bhutto LA. Role of laser peripheral iridoplasty in acute attack of primary angle closure glaucoma[J]. Pak J Ophthalmol, 2010, 26(3): 154-157.
[35]
Lim AS, Tan A, Chew P, et al. Laser iridoplasty in the treatment of severe acute angle closure glaucoma[J].Int Ophthalmol, 199317(1): 33-36.
[36]
Lam DS, Tham CC, Lai JS, et al. Current approaches to themanagement of acute primary angleclosure[J]. Curr Opin Ophthalmol, 200718(2): 146-151.
[37]
Lai JS, Tham CC, Chua JK, el al.Laser peripheral iridoplasty as initial treatment of acute attack of primary angle-closure: a long-term follow-up study[J].J Glaucoma, 2002, 11(6): 484-487.
[38]
孙霞,梁远波,李思珍,等. 急性闭角型青光眼治疗方法的循证评价[J].中国实用眼科杂志2008, 8(8): 769-774.
[39]
Lam DSC, Lai JSM, Tham CCY. Immediate argon laser peripheral iridoplasty as treatment for acute attack of primary angle closure glaucoma: a preliminary study[J]. Ophthalmology, 1998, 105(1): 2231-2236.
[40]
Lam DSC, Lai JSM, Tham CCY, et al. Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle closure glaucoma[J]. Ophthalmology, 2002, 109(9): 1591-1596.
[41]
Kunimatsu-Sanuki S, Iwase A, Tomidokoro A, et al. Factors related to future peripheral anterior synechiae formation on ultrasound biomicroscopy: 7-year follow-up in eyes with shallow peripheral anterior chambers[J]. J Glaucoma, 2014, 23(4): 202-205.
[42]
Sun X, Liang YB, Wang NL, et al. Laser peripheral iridotomy with and without iridoplasty for primary angle-closure glaucoma: 1-year results of a randomized pilot study[J].Am J Ophthalmol, 2010150(1): 68-73.
[43]
韩伟,郭黎霞,范肃洁. 激光周边虹膜成形术治疗药物难控制性急性闭角型青光眼的房角观察[J]. 国际眼科杂志2013, 13(7): 1382-1384.
[1] 吴洋, 吴镜, 杨永清, 刘婧, 王丹妮, 张哲梅. AECOPD并发呼吸衰竭患者凝血与纤溶指标检测的临床意义[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 853-855.
[2] 蒋静, 周敏杰, 季江. AECOPD患者血清PCT/Lac、CRP检测及临床意义[J]. 中华肺部疾病杂志(电子版), 2022, 15(05): 682-684.
[3] 雷娇, 倪丹红. 孟鲁司特钠对儿童哮喘急性发作期的疗效及气道功能的影响[J]. 中华肺部疾病杂志(电子版), 2021, 14(05): 611-613.
[4] 蔡辉, 胡航, 曹亚. 中性粒细胞胞外诱捕网水平联合肺功能对哮喘急性发作预测意义[J]. 中华肺部疾病杂志(电子版), 2021, 14(05): 599-601.
[5] 易婷婷, 张利华. 喘可治在儿童支气管哮喘急性发作期治疗的临床应用[J]. 中华肺部疾病杂志(电子版), 2021, 14(01): 87-89.
[6] 魏胜全, 薛华, 薛慧君. 糠酸氟替卡松/维兰特罗对慢性阻塞性肺疾病急性发作期的影响[J]. 中华肺部疾病杂志(电子版), 2020, 13(05): 602-606.
[7] 吴文娜, 赵博. 支气管镜肺泡灌洗联合NIPPV治疗AECOPD并2型呼吸衰竭临床分析[J]. 中华肺部疾病杂志(电子版), 2020, 13(02): 204-208.
[8] 施娟, 姜树中, 潘剑蓉. 孟鲁司特钠与布地奈德混悬液联合治疗对哮喘急性发作患儿肺功能和C-反应蛋白的影响[J]. 中华肺部疾病杂志(电子版), 2019, 12(03): 358-360.
[9] 黄海川. 支气管扩张剂联合皮质激素对儿童支气管哮喘急性发作的临床分析[J]. 中华肺部疾病杂志(电子版), 2017, 10(01): 81-82.
[10] 杨蕾, 刘姗姗, 范晓军, 王一涵, 张燕妮, 徐嘉轶, 王继兵. 自制眼内前房角镜-分离器行前房角分离联合超声乳化白内障吸除及后房型人工晶状体植入术治疗原发性闭角型青光眼的临床研究[J]. 中华眼科医学杂志(电子版), 2023, 13(03): 140-145.
[11] 金杉杉, 熊琨, 王璐, 梁远波. 中国青光眼流行趋势及特征的Meta分析[J]. 中华眼科医学杂志(电子版), 2022, 12(06): 332-340.
[12] 郭丽, 杨一佺, 郭黎霞, 吕爱国, 苗慧, 韩伟, 胡建华, 范肃洁. 激光瞳孔成形术与激光周边虹膜成形术治疗急性原发性前房角关闭的临床研究[J]. 中华眼科医学杂志(电子版), 2022, 12(01): 12-17.
[13] 王芳, 王雪, 吴志鸿, 汪东生. 单纯超声乳化白内障吸除联合后房型人工晶状体植入术治疗原发性闭角型青光眼疗效的临床观察[J]. 中华眼科医学杂志(电子版), 2019, 09(01): 7-13.
阅读次数
全文


摘要